Aaron Foster Net Worth

The estimated Net Worth of Aaron E. Foster is at least $562 dollars as of 2 January 2020. Aaron Foster owns over 3,125 units of Bellicum Pharmaceuticals Inc stock worth over $562 and over the last 5 years he sold BLCM stock worth over $0. In addition, he makes $0 as Senior Vice President and Head of Research at Bellicum Pharmaceuticals Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Aaron Foster BLCM stock SEC Form 4 insiders trading

Aaron has made over 1 trades of the Bellicum Pharmaceuticals Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 3,125 units of BLCM stock worth $234 on 2 January 2020.

The largest trade he's ever made was exercising 3,125 units of Bellicum Pharmaceuticals Inc stock on 2 January 2020 worth over $234. On average, Aaron trades about 781 units every 0 days since 2019. As of 2 January 2020 he still owns at least 7,517 units of Bellicum Pharmaceuticals Inc stock.

You can see the complete history of Aaron Foster stock trades at the bottom of the page.

Aaron Foster biography

Dr. Aaron A. Foster Ph.D. serves as Senior Vice President, Head of Research of the Company. Dr. Foster has served as our Senior Vice President, Head of Research since March 2019. Since joining us as a Senior Scientist in March 2012, Dr. Foster has held roles of increasing responsibility, including Vice President, Translational Research and New Product Development, from June 2016 to March 2019, Senior Director of Product Discovery, from February 2015 to June 2016, Director of Product Discovery, from February 2014 to February 2015, and Principal Scientist from January 2013 to January 2014. Prior to joining us in 2012, Dr. Foster was an Assistant Professor at Baylor College of Medicine at the Center for Cell and Gene Therapy, where he led a group researching adoptive T cell therapies, cancer vaccines and nanotherapeutics. He received his B.A. in Biology from the University of Puget Sound and his Ph.D. in Chemical Engineering from the University of Sydney.

How old is Aaron Foster?

Aaron Foster is 47, he's been the Senior Vice President and Head of Research of Bellicum Pharmaceuticals Inc since 2019. There are 12 older and 4 younger executives at Bellicum Pharmaceuticals Inc. The oldest executive at Bellicum Pharmaceuticals Inc is Dr. Alan K. Smith Ph.D., 63, who is the Chief Scientific Officer.

What's Aaron Foster's mailing address?

Aaron's mailing address filed with the SEC is C/O BELLICUM PHARMACEUTICALS, INC., 2130 W. HOLCOMBE BLVD., STE. 800, HOUSTON, TX, 77030.

Insiders trading at Bellicum Pharmaceuticals Inc

Over the last 10 years, insiders at Bellicum Pharmaceuticals Inc have traded over $18,000,835 worth of Bellicum Pharmaceuticals Inc stock and bought 249,666 units worth $2,145,232 . The most active insiders traders include Bros. Advisors Lp Baker Bro..., Bros. Advisors Lpbaker Feli..., and Jon P Stonehouse. On average, Bellicum Pharmaceuticals Inc executives and independent directors trade stock every 32 days with the average trade being worth of $2,494. The most recent stock trade was executed by James M Daly on 3 January 2023, trading 60,414 units of BLCM stock currently worth $4,516.

What does Bellicum Pharmaceuticals Inc do?

bellicum pharmaceuticals, located near the houston medical center, is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. we are developing next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (hsct) and car t cell therapy. we are dedicated to creating an exceptional work environment and are passionate about working to provide innovative new treatment options that can improve health and save lives.

Complete history of Aaron Foster stock trades at Bellicum Pharmaceuticals Inc

Bellicum Pharmaceuticals Inc executives and stock owners

Bellicum Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Richard Fair,
  President, Chief Executive Officer, Director
• Richard A. Fair,
  Pres, CEO & Director
• Shane Ward,
  Corporate Secretary, Chief Legal and Strategy Officer
• Charity D. Scripture M.S., Pharm.D.,
  Chief Devel. Officer
• James Brown,
  Independent Chairman of the Board
• Jon Stonehouse,
  Independent Director
• Reid Huber,
  Independent Director
• Stephen Davis,
  Independent Director
• Judith Klimovsky,
  Independent Director
• James Daly,
  Independent Director
• David Strauss,
  Corporate Controller
• Aaron Foster,
  Senior Vice President, Head of Research
• Atabak Mokari,
  Chief Financial Officer
• Charity Scripture,
  Chief Devel. Officer
• Dr. Aaron E. Foster,
  Head of Research & Sr. VP
• Dr. Alan K. Smith Ph.D.,
  Chief Scientific Officer
• Joseph Senesac,
  Sr. VP of Technical Operations & Quality
• Charles S. Grass,
  Principal Accounting Officer
• Alan A Musso,
  CFO and Treasurer
• Thomas J. Farrell,
  President and CEO
• Frank B. Mc Guyer,
  Director
• Alan K. Smith,
  EVP, Technical Operations
• Ken Moseley,
  Vice President
• Kevin M. Slawin,
  CMO and CTO
• Bros. Advisors Lpbaker Feli...,
  
• Peter L. Hoang,
  Sr. VP of Bus. Development
• Annemarie Moseley,
  Chief Operating Office and EVP
• Rosemary Y. Williams,
  VP, Finance & PAO
• Gregory S. Naeve,
  Chief Business Officer
• Bros. Advisors Lp Baker Bro...,
  
• Edmund Harrigan,
  Director
• William Grossman,
  Sr. VP, Chief Medical Officer
• David M. Spencer,
  Chief Scientific Officer
• Jr Joseph Paul Woodard,
  SVP Clinical & Medical Affairs
• Joseph Senesac,
  VP of Manufacturing
• Investments Ltd. Mc Guyer,
  10% owner
• Ventures Llc Remeditex,
  10% owner
• Charity Scripture,
  Chief Development Officer
• Bros. Advisors Lpbaker Juli...,